199 related articles for article (PubMed ID: 37749461)
21. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
[TBL] [Abstract][Full Text] [Related]
22. Improving the accuracy of prognosis for clinical stage I solid lung adenocarcinoma by radiomics models covering tumor per se and peritumoral changes on CT.
Liu K; Li K; Wu T; Liang M; Zhong Y; Yu X; Li X; Xie C; Zhang L; Liu X
Eur Radiol; 2022 Feb; 32(2):1065-1077. PubMed ID: 34453574
[TBL] [Abstract][Full Text] [Related]
23. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
[TBL] [Abstract][Full Text] [Related]
24. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
Mei D; Luo Y; Wang Y; Gong J
Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract][Full Text] [Related]
26. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
27. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
[TBL] [Abstract][Full Text] [Related]
28. A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis.
Yu Z; Xu C; Zhang Y; Ji F
BMC Med Imaging; 2022 Jul; 22(1):133. PubMed ID: 35896975
[TBL] [Abstract][Full Text] [Related]
29. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
[TBL] [Abstract][Full Text] [Related]
30. Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma.
Li X; Chen J; Zhang C; Han Z; Zheng X; Cao D
BMC Pulm Med; 2023 Sep; 23(1):339. PubMed ID: 37697337
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
Tang X; Huang H; Du P; Wang L; Yin H; Xu X
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
[TBL] [Abstract][Full Text] [Related]
32. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
[No Abstract] [Full Text] [Related]
33. Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.
Lu J; Ji X; Wang L; Jiang Y; Liu X; Ma Z; Ning Y; Dong J; Peng H; Sun F; Guo Z; Ji Y; Xing J; Lu Y; Lu D
Dis Markers; 2022; 2022():2056837. PubMed ID: 35578691
[TBL] [Abstract][Full Text] [Related]
34. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
35. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
[TBL] [Abstract][Full Text] [Related]
36. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
[TBL] [Abstract][Full Text] [Related]
37. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
[TBL] [Abstract][Full Text] [Related]
38. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ
Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476
[TBL] [Abstract][Full Text] [Related]
39. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC.
Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W
Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]